Anastasios Papanagnou

Anastasios Papanagnou practices at Peekskill Cortlandt Dialysis Center in Ossining, New York.

Anastasios Papanagnou's NPI, 1245632728, was assigned on September 16, 2014. Anastasios Papanagnou graduated from SUNY Downstate Health Sciences University in 2013. Anastasios Papanagnou holds New York license 291768.

Anastasios Papanagnou's primary practice is Peekskill Cortlandt Dialysis Center, at 47 Hudson St, Ossining, NY 10562 in Westchester County. The practice phone is (914) 788-9326.

Anastasios Papanagnou's primary practice is Peekskill Cortlandt Dialysis Center in Ossining, New York. Anastasios Papanagnou is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is The Westchester Medical Practice. Dmand AI also links Anastasios Papanagnou to 1 more hospital, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anastasios Papanagnou practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Anastasios Papanagnou's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Anastasios Papanagnou is board certified in internal medicine by the American Board of Internal Medicine. Anastasios Papanagnou is licensed in New York.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Anastasios Papanagnou treats.

CMS data shows 1,422 Medicare services from Anastasios Papanagnou across 8 procedure codes in 2024, for 359 Medicare patients. Medicare paid $157,678 for them.

CMS counts 359 Medicare patients who saw Anastasios Papanagnou in 2024. The largest group is 75 to 84, with 142 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 3.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anastasios Papanagnou's median patient age at 70, with 47% women.

In 2024, Anastasios Papanagnou wrote 723 Medicare Part D claims for 144 patients. 88% of them were for generic drugs. CMS names the drug for 576 of them, across 14 drugs with 11 or more claims each, at $79,613 in total drug cost. In 2023, CMS named 637 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Anastasios Papanagnou for performance year 2024, reported through an alternative payment model (APM). Anastasios Papanagnou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Anastasios Papanagnou as offering telehealth.

CMS Open Payments shows 36 general payments to Anastasios Papanagnou from 16 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 84% of the total. Alexion Pharmaceuticals, Inc. paid the most, $643.

Anastasios Papanagnou graduated from SUNY Downstate Health Sciences University in 2013.

Anastasios Papanagnou is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.